Important Research of the Past Year in the Field of Mood Disorders: Studies on Treatment Options in Bipolar Disorder


Creative Commons License

Korkmaz Ş. A.

Türkiye Psikiyatri Derneği YILLIK TOPLANTISI VE 2.ULUSLARARASI 26. ULUSAL KLİNİK EĞİTİM SEMPOZYUMU, Mersin, Türkiye, 9 - 12 Mayıs 2024, ss.27, (Özet Bildiri)

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Mersin
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.27
  • Çanakkale Onsekiz Mart Üniversitesi Adresli: Evet

Özet

This presentation aimed to review emerging or over-the-horizon therapies for treating BD. Published in 2023 and the first period of 2024, systematic reviews and meta-analyses related to BD treatments, the efficacy of new antipsychotic agents such as lumateperone, olanzapine/samidorphan, and aripiprazole 2-month long-acting injectable in BD treatments, duration of use of antidepressant add-on treatments in bipolar depression, cannabidiol add-on strategies in bipolar depression, the effect of age on the anti-suicidal efficacy of lithium, the effectiveness of esketamine in treatment-resistant bipolar depression, the effectiveness of psilocybin-assisted psychotherapy in treatment-resistant bipolar depression, the role of anti-inflammatory agents in the adjunctive treatment of bipolar mania and bipolar depression and many other issues related to the treatment of BD will be discussed.